Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10882898 Human immunodeficiency virus neutralizing antibodies

Patent 10882898 was granted and assigned to Gilead Sciences on January, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Xue Zhang0

John Corbin0

Mini Balakrishnan0

Nathan D. Thomsen0

Brian A. Carr0

Craig S. Pace0

Date of Patent

January 5, 2021

0

Patent Application Number

162737530

Date Filed

February 12, 2019

0

Patent Citations

US Patent 10087239 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

0

US Patent 10184000 Optimized Fc variants and methods for their generation

0

US Patent 10336818 Fc variants with altered binding to FcRn

US Patent 10584176 Fc variants with increased affinity for FcγRIIc

Patent Citations Received

US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

0

Patent Primary Examiner

Nicole Kinsey White

0

Patent abstract

The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10882898 Human immunodeficiency virus neutralizing antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool